Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
CN¥ 43.19
Key Takeaways
Risk factor
Strong & resilient to price shocks
Data is available to registered users only
Data is available to registered users only
Profitability factor
Strong margins and returns
Data is available to registered users only
Data is available to registered users only
About
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited, together with its subsidiaries, produces and sells traditional Chinese medicine, western medicine, and healthcare products primarily in the People's Republic of China. It operates in Chinese Medicine and Western Medicine segments. The company is also involved in the manufacture and sale of Chinese and western pharmaceutical and...
Company Valuation
Considering past and projected metrics, the stock is neither 'expensive' nor 'cheap' compared to its peers. Specifically, the stock is 'cheap' on P/E, overvalued on EV/EB
Data is available to registered users only
Buy
Sell